Introduction
Increased oxidative stress has been reported in vascular diseases and is implicated in the alteration of vascular function. Clinical and experimental studies have shown that endogenous or exogenous reactive oxygen species (ROS) can modulate vascular tone and perhaps mediate signal transduction [1] [2] [3] [4] . In different vascular beds and under different conditions, ROS has been reported to mediate varied vascular functions, such as vasoreactivity, vascular proliferation, and vascular cell signaling [4] [5] [6] [7] . Such actions depend on the particular pathophysiological condition. In cardiovascular diseases, increased oxidative stress and the increased production of vasoconstrictor agents, such as catecholamine, angiotensin, thromboxane, and endothelin-1 (ET-1) have been reported and implicated in the pathogenesis of vascular dysfunction [3, 4, [7] [8] [9] [10] . Under such pathological conditions, there is the possibility that vasoactive agents can recruit different ROS components to modulate distinct vascular functions. Such interactions will depend on the vascular environment, type, and levels of vasoactive agents (constrictors/dilators) present in that particular vascular bed [10] [11] [12] [13] [14] .
Abstract
Aim: We tested the hypothesis that bradykinin (BK)-induced relaxation of phenylephrine (PE) and endothelin-1 (ET-1) contractions can be differentially modulated by reactive oxygen species (ROS). Methods: Aortic rings isolated from Sprague-Dawley rats were used for the study. The contribution of ROS to PE (1×10 -5 mol/L) relaxation of PE (1×10 -7 mol/L) or ET-1 (1×10 -9 mol/L)-induced tension was evaluated in the aorta in the presence or absence of the following antioxidants: catalase (CAT, 300 U/mL), superoxide dismutase (SOD, 300 U/mL), and vitamin C (1×10 -4 mol/L). Results: Tension generated by ET-1 (1×10 -9 mol/L) or PE (1×10 -7 mol/L) was differentially relaxed by BK (1×10 -5 mol/L), producing a maximal relaxation of 75%±5% and 35±4%, respectively. The BK (1×10 -5 mol/L)-induced relaxation of PE (1×10 -7 mol/L) tension was significantly enhanced from 35%±4% (control) to 56%±9%, 60%±5%, and 49%±6% by SOD, CAT, and vitamin C, respectively (P<0.05, n=8). However, the relaxation of ET-1 (1×10 -9 mol/L) tension was significantly attenuated from 75%±5% (control) to 37%±9%, 63%±4%, and 39%±7% by SOD, CAT, and vitamin C, respectively (P<0.05, n=8). On the other hand, CAT had no effect on PE-induced tension, while SOD enhanced PE-induced tension (36%, P<0.05, n=10) and vitamin C attenuated (66%, P<0.05, n=8) the tension induced by PE. By contrast, SOD or vitamin C had no effect, but CAT attenuated (44%, P<0.05, n=9) the tension induced by ET-1.
Conclusion:
We have demonstrated that O 2 -and H 2 O 2 differentially modulate BK relaxation in an agonist-specific manner. O 2 -attenuates BK-induced relaxation of PE contraction, but contributes to the relaxation of ET-1 contraction. O 2 -seems to inhibit PE contraction, while H 2 O 2 contributes to ET-1-induced contraction. Thus, ROS differentially modulate vascular tone depending on the vasoactive agent that is used to generate the tone.
The origin of ROS produced in activated vascular cells, including superoxide and H 2 O 2 has been a subject of several studies and the use of different oxidase inhibitors and/or substrates have identified membrane-associated oxidase inhibited by flavin oxidase inhibitors and stimulated by NADH or NADPH, suggesting that NAD(P)H oxidases are an important source of superoxide production in the vascular system of several animals [3, 6, 15, 16] . In the cardiovascular system, NAD(P)H oxidases are membrane-associated enzymes which catalyze reduction of oxygen using electrons donated by NADH or NADPH. Upon stimulation by vasoactive agents, O 2 _ is produced within minutes to hours by endothelial cells and vascular smooth muscle cells. Recent evidence further indicates that lipoxygenase, cyclooxygenase, mitochondrial oxidases, xanthine oxidase, and nitric oxide (NO) synthases are also sources of ROS [3, 4, 6, [16] [17] [18] . Bradykinin (BK) is an important vasoactive agent which is released by the vascular system especially during inflammatory processes, including ischemia reperfusion and other conditions which may involve the generation of ROS. BK can modulate vascular functions via numerous mechanisms, including the release of prostanoids, NO, the regulation of intracellular calcium ions, the activation of potassium channels, and ROS generation [9, [19] [20] [21] [22] [23] . The varied vascular actions of BK and the mechanisms by which they are accomplished are vascular bed-dependent [19] [20] [21] [22] [23] [24] . For example, in the brain, BK has been reported to cause cerebrovascular dilation through the activation of Ca 2+ -activated potassium channels, the endothelium-derived hyperpolarizing factor, and NO [22] [23] [24] , while in the peripheral vessels it acts through the release of NO, prostanoids, activation of K + channel, ROS generation, or the release of hyperpolarizing factors [19] [20] [21] [22] . In this study, we investigated the hypothesis that ROS contributes to BK relaxation and that the relaxation is differentially modulated in the presence of phenylephrine (PE) and ET-1-induced contractions.
Superoxide dismutase (SOD; a superoxide scavenger), catalase (CAT; a hydrogen peroxide scavenger), and vitamin C (a non-selective antioxidant) were used to test the working hypothesis. We characterized the involvement of ROS in the BK relaxation of ET-1-and PE-induced contractions and compared the contribution of ROS to PE-and ET-1-generated tension.
Materials and methods
Drugs and chemicals SOD, CAT, vitamin C, bradykinin, PE, acetylcholine, and ET-1 were purchased from SigmaAldrich (St Louis, MO, USA).
Experimental animals Male Sprague-Dawley rats (250-300 g; purchased from Harlan, Houston, TX, USA), were used for this study and maintained according to the National Institute of Health NIH guidelines on the care and use of laboratory animals (Texas Southern University, Houston, TX, USA). The protocol used for this study was approved by the Animal Care Committee of the Texas Southern University.
Tissue preparation Following anesthesia with urethane (2 g/kg; ip), the chest cavity was opened and the thoracic aorta was removed and placed in a petri dish containing cold Kreb's (4 o C) solution (in mmol/L, NaCl 113, KCl 4.7, NaHCO 3 25.0, CaCl 2 2.5, KH 2 PO 4 1.2, MgSO 4 1.2, and glucose 5, pH 7.4) and continuously gassed with 95% O 2 and 5% CO 2 . The aorta was cleansed of connective tissues and cut into 3-4 mm rings. The aortic ring was then mounted in a 10 mL jacketed bath (World Precision Instruments, Sarasota, FL, USA) at 37 °C. The ring was suspended in the bath solution by 2 hooks; the lower one fixed to the bottom of the bath while the upper one was connected via a transbridge (model TBM4, World Precision Instruments, USA) data-acquisition system (DataQ Instruments, Akron, OH, USA) for the recording of isometric tension developed to the application of vasoactive agents. The rings were subjected to a resting tension of 2 g and allowed to equilibrate for a period of 90 min while being rinsed every 15 min. During the equilibration period, the rings were subjected to 2 challenges of 1×10 -7 mol/L PE 30 min apart and relaxed with 1×10 -5 mol/L acetylcholine to test the functionality of the tissues. Tissues that did not produce 70%-80% relaxation of the tension generated were considered non-responsive and were excluded from the study. Changes in tension were monitored via a force displacement transducer connected to a DI-720 system (DATAQ software, USA).
Cumulative dose-response curves Following a 90 min equilibration, the aortic rings were preconstricted with PE (1×10 -7 mol/L) or ET-1 (1×10 -9 mol/L). The concentration of PE or ET-1 used was shown in preliminary experiments to produce about 70% of maximal contraction. The contraction to PE or ET-1 was allowed to reach a plateau and stabilize (5-10 min) before the relaxation studies com-menced. The relaxation responses to the cumulative concentrations of BK (1×10
-5 mol/L) were determined in the absence or presence of antioxidants: SOD (300 U/mL; a superoxide scavenger), CAT (300 U/mL; a hydrogen peroxide scavenger), or vitamin C (1×10 -4 mol/L; a scavenger of superoxide, hydroxyl radicals, and hydrogen peroxide). The concentrations of the antioxidants and other agents used were consistent with those reported by us and others [4, 14, 25] .
The contribution of ROS to the contraction induced by PE or ET-1 was investigated by evaluating the dose-dependent contraction of the aortic ring to PE or ET-1 (1×10 -10 -
1×10
-6 mol/L) in the absence or presence of SOD, CAT, or vitamin C.
Statistical analysis Vascular relaxation responses are presented as percentage change in the relaxation of the aortic ring from preconstricted values following the addition of BK. The contraction responses to PE or ET-1 are presented as tension in grams. Data are reported as mean±SEM and subjected to two-way ANOVA followed by Student-NewmanKeul's post-hoc test. P<0.05 was considered statistically significant.
Results
The application of PE (1×10 -7 mol/L) to the aortic ring preparation resulted in the development of tension that attained a plateau in 3-5 min. The average tension developed to PE application was 1.69±0.19 g (n=10). ET-1 (1×10 -9 mol/L) application resulted in slow-developing tension which attained plateau in 7-10 min with an average tension of 1.82±0.18 g (n=10).
BK (1×10 -5 mol/L) dosedependently relaxed PE-induced tension. Pretreatment of the ring with SOD (300 U/mL), CAT (300 U/mL), or vitamin C (1×10 -4 mol/L) for 15 min significantly enhanced the BK relaxation of PE contraction. At the highest concentration of BK (1×10 -5 mol/L) employed, the relaxation to BK was significantly increased from 35%±4% relaxation in the control to 56%±9%, 60%±5%, or 49%±6%, respectively, for SOD, CAT, or vitamin C (Figure 1, P<0.05, n=8, ANOVA) .
BK dose-dependently relaxed ET-1-induced contraction Unlike PE, the BK relaxation of ET-1 tension was significantly attenuated by pretreatment with SOD, CAT, or vitamin C (Figure 2) . Thus, at the highest concentration (1×10 -5 mol/L), BK-induced relaxation was reduced from 75%±5% (control) to 37%±9% (SOD), 63±3% (CAT), or 39%±7% (vitamin C) following 15 min pre-incubation (Figure 2 , P< 0.05, ANOVA, n=8).
Contribution of ROS to PE-and ET-1-induced contraction of the aortic ring The effects of pre-incubation with SOD, CAT, or vitamin C on PE-induced contraction of the aortic ring was determined (Figure 3) . PE dose-dependently contracted the aortic rings and pre-incubation with SOD (300 U/mL) significantly enhanced PE contraction by 36%. PE tension increased from 1.69±0.19 g (control) to 2.30±0.14 g (SOD) ( Figure 3A, P<0.05, n=10, ANOVA) . Preincubation with CAT (300 U/mL) had no significant effects on PE-induced contraction (1.69±0.19 g) in the control 
Discussion
This study revealed that: (i) BK evoked dose-dependent relaxation of ET-1-and PE-contracted aortic rings, producing a greater relaxation of ET-1-induced tension than that by PE; (ii) pretreatment with antioxidants enhanced BK relaxation of PE tension, but attenuated its relaxation of ET-1 tension; (iii) PE-induced contraction was enhanced by pretreatment of aortic rings with SOD, but not vitamin C or CAT; and (iv) ET-1-induced contraction was attenuated by pretreatment of the aortic rings with CAT, but not SOD or vitamin C. The results presented generally support a differential role for ROS in BK-induced vascular relaxation of PEand ET-1-induced contraction and that the contribution of free radical species for the generation of tension by ET-1 or PE is agonist specific. O 2 -negatively modulated PE contraction while H 2 O 2 positively modulated ET-1-induced contraction.
It is now well established that various stimuli can induce increased production of ROS in vascular cells [4, 6, 10, 26, 27] . ROS produced in activated vascular cells can come from different oxidases, for example, xanthine/xanthine oxidase, mitochondrial oxidase, and arachidonic acid oxygenases, including the NADPH oxidase in the vascular wall [3, 6, 7, 28, 29] . The ROS usually produced primarily is superoxide which undergoes dismutation to H 2 O 2 , another potent ROS. Results from various laboratories support the role of ROS in vascular function in response to different vasoconstrictors and vasodilators. For example, PE via its activation of α 1 -receptors or ET-1 via the activation of ET A receptors could potentially generate ROS via the stimulation of protein kinase C (PKC), Ca 2+ channels, or arachidonic acid metabolites [4, 7, 10, 27, 30, 31] . In view of the similarity in signaling mechanisms between different constrictor and relaxant agents, it is difficult to specifically identify the exact source(s) of ROS or their qualitative effects in a particular preparation. In the cardiovascular system, NAD(P)H oxidases are membrane-associated enzymes which catalyze the reduction of oxygen using electrons donated by NADH or NADPH. Upon stimulation by vasoactive agents, O 2 -is produced within minutes to hours by endothelial cells and vascular smooth muscle cells and is considered the main source of free radical generation in the vascular system [6, 7, 15, 16] . In this study, we addressed the differential effects of ROS on PE-and ET-1 contraction of the rat aorta and characterized the relaxant effects of BK in tissues in which tension was generated with PE or ET-1 in order to evaluate the differential role of ROS. In the PE-contracted preparations, ROS appeared to contribute to BK-induced relaxation inasmuch as antioxidant treatment with SOD, CAT, or vitamin C resulted in enhanced relaxation. Although the exact mecha- -which may reduce the availability of NO that is potentially released by BK. Consistent with this observation is the reported involvement of ROS in vascular signaling via α 1 -adrenoceptors in which the inhibition by the SOD mimetic was accompanied by a decrease in ROS generation and release in vascular tissue as well as tone [31] . Also, it is possible that BK-induced relaxation may be blunted by a PE-induced increase in the O 2 -level leading to the neutralization of NO [1, 3, 7, 10, 31] . Thus, SOD mitigated this effect and preserved NO leading to the enhanced relaxation ( Figure 1A ). Consistent with this notion is the enhanced BK relaxation of PE tension following treatment of the aortic ring with vitamin C, an antioxidant and the reported attenuation of BK relaxation during high oxidative stress [3, 4, 19, 22] . This observation finds support in the finding that vitamin C via its antioxidant properties can stabilize cofactors for eNOS (tetrahydrobiopterin) [7, 32] , thereby preserving NO bioavailability and promoting relaxation. The degree of enhancement of the relaxation evoked by BK was similar in the tissues treated with SOD or CAT indicating that both O 2 -and H 2 O 2 in the PEcontracted aorta are equally effective and negatively coupled to BK relaxation. Vitamin C, a non-selective antioxidant, enhanced the BK-induced relaxation of PE tension, but surprisingly, to a lower extent than that observed in the presence of SOD or CAT. The reason for this is not clear. However, as ROS are known to produce contraction and/or relaxation in the same preparation [17, 28, 29, [33] [34] [35] , and because of its non-selective effects, we speculate that the final effect on vascular response will be the net effect of vitamin C on ROS that produces contractile or relaxant effects.
In the ET-1-contracted aorta, ROS produced effects opposite to that in the PE-contracted aorta and attenuation rather than enhancement of relaxation resulted when the ET-1-contracted aorta was challenged with antioxidants. Comparing the degree of attenuation, O 2 -exerted a greater role than H 2 O 2 as SOD produced a greater (38%) attenuation of BK relaxation than CAT (10%). On the other hand, the effects produced by vitamin C were similar in magnitude to that produced by SOD (36%), suggesting that O 2 -is the predominant ROS playing a greater role in the BK relaxation of ET-1-contracted aorta. The minimal effect of CAT is consistent with the studies of Ellis et al [14] in the mouse isolated aorta. It thus appears that in an ET-1-contracted tissue, O 2 -produced relaxation while H 2 O 2 produced contraction, a notion supported by studies that demonstrated relaxation and contractile effects to O 2 -or H 2 O 2 , respectively [17, 33, 34] . This being the case, BK may have produced relaxation via O 2 -in the process of a cyclooxygenase (COX)-dependent prostaglandin production, a known mechanism for the relaxant effects of BK. In preparations incubated with SOD and challenged with ET-1, the dismutation of O 2 -to a contractile superoxide anion may therefore have accounted for the enhanced tone to ET-1. Also, the vasoconstrictor actions of H 2 O 2 has been attributed to its ability to increase intracellular Ca 2+ , the generation of arachidonic acid metabolites with vasoconstrictor activity, and to its direct Ca 2+ -independent tonic effects on vascular smooth muscle contractile apparatus [11, 33, 34, 36, 37] . Apart from relaxation of the aortic ring, the contribution of ROS to PE-or ET-1-induced contraction was also investigated. Pretreatment with antioxidants resulted in the selective regulation of tension generated by PE and ET-1. Thus, PE-induced contraction was enhanced by an O 2 -scavenger (SOD) indicating that O 2 -contributes a negative tone to vessels challenged with PE. On the other hand, increased H 2 O 2 level resulting from the SOD-induced dismutation of O 2 -did not influence PE contraction. However, ET-1-induced contraction was attenuated by CAT, but not by SOD or vitamin C, indicating that H 2 O 2 contributed to ET-1-induced contraction, but not PE-induced contraction. This is consistent with studies that have reported that H 2 O 2 causes vasoconstriction [17, 34, 35] . Thus, the contribution of free radical species to the generation of tension by ET-1 or PE is agonist specific and the contribution of free radicals to BK relaxation is also agonist specific, resulting in a differential modulation of its relaxation. This differential effect may be a reflection of the interaction of the multiple signaling processes, for example, phospholipase C, PKC, mitogen-activated protein kinases, and intracellular Ca 2+ involved in BK relaxation, PE or ET-1 contraction, and ROS generation. These mechanisms are further complicated by the fact that PE and ET-1 are potent stimulators of vascular superoxide generation [6, 26, 28, 29, 31, 37, 38] . It therefore appears that different mechanisms involved in ROS generation and agonist-induced signaling mechanisms will define the resulting vascular responses to vasoconstrictors and dilators in a particular tissue.
